Oric Pharmaceuticals (ORIC) Total Current Liabilities (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Total Current Liabilities came in at $17.8 million in Q1 2026, up 0.87% YoY from $17.6 million in Q1 2025, and down 12.96% on a QoQ basis from $20.4 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Total Current Liabilities (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Total Current Liabilities data on file, last reported at $17.8 million in Q1 2026.
- Quarterly Total Current Liabilities rose 0.87% year-over-year to $17.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.8 million (up 0.87% YoY) and the FY2025 annual result came in at $20.4 million, down 17.83% from the prior year.
- Total Current Liabilities eased to $17.8 million in Q1 2026, from $20.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $24.8 million in Q4 2024 to a low of $11.8 million in Q1 2022.
- A 5-year average of $17.4 million and a median of $17.8 million in 2026 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 53.95% — and 2025, when it slipped 17.83%.
- Tracing ORIC's Total Current Liabilities over 5 years: stood at $15.4 million in 2022, then surged by 32.95% to $20.5 million in 2023, then climbed by 21.45% to $24.8 million in 2024, then fell by 17.83% to $20.4 million in 2025, then slipped by 12.96% to $17.8 million in 2026.
- The last three Total Current Liabilities figures came in at $17.8 million (Q1 2026), $20.4 million (Q4 2025), and $20.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | 20.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.76 Mn |
| Mar 31, 2026 | 17.77 Mn |
| Dec 31, 2025 | 20.42 Mn |
| Sep 30, 2025 | 20.18 Mn |
| Jun 30, 2025 | 18.05 Mn |
| Mar 31, 2025 | 17.62 Mn |
| Dec 31, 2024 | 24.85 Mn |
| Sep 30, 2024 | 21.25 Mn |
| Jun 30, 2024 | 19.54 Mn |
| Mar 31, 2024 | 15.21 Mn |
| Dec 31, 2023 | 20.46 Mn |
| Sep 30, 2023 | 18.94 Mn |
| Jun 30, 2023 | 14.53 Mn |
| Mar 31, 2023 | 14.87 Mn |
| Dec 31, 2022 | 15.39 Mn |
| Sep 30, 2022 | 13.28 Mn |
| Jun 30, 2022 | 12.47 Mn |
| Mar 31, 2022 | 11.82 Mn |
| Dec 31, 2021 | 15.15 Mn |
| Sep 30, 2021 | 11.90 Mn |